Cargando…
A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment
The development of selective tumor targeting agents to deliver multiple units of chemotherapy drugs to cancer tissue would improve treatment efficacy and greatly advance progress in cancer therapy. Here we report a new drug delivery system based on a tetrabranched peptide known as NT4, which is a pr...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179244/ https://www.ncbi.nlm.nih.gov/pubmed/32121130 http://dx.doi.org/10.3390/molecules25051088 |
_version_ | 1783525630023827456 |
---|---|
author | Brunetti, Jlenia Piantini, Sara Fragai, Marco Scali, Silvia Cipriani, Giulia Depau, Lorenzo Pini, Alessandro Falciani, Chiara Menichetti, Stefano Bracci, Luisa |
author_facet | Brunetti, Jlenia Piantini, Sara Fragai, Marco Scali, Silvia Cipriani, Giulia Depau, Lorenzo Pini, Alessandro Falciani, Chiara Menichetti, Stefano Bracci, Luisa |
author_sort | Brunetti, Jlenia |
collection | PubMed |
description | The development of selective tumor targeting agents to deliver multiple units of chemotherapy drugs to cancer tissue would improve treatment efficacy and greatly advance progress in cancer therapy. Here we report a new drug delivery system based on a tetrabranched peptide known as NT4, which is a promising cancer theranostic by virtue of its high cancer selectivity. We developed NT4 directly conjugated with one, two, or three units of paclitaxel and an NT4-based nanosystem, using NIR-emitting quantum dots, loaded with the NT4 tumor-targeting agent and conjugated with paclitaxel, to obtain a NT4-QD-PTX nanodevice designed to simultaneously detect and kill tumor cells. The selective binding and in vitro cytotoxicity of NT4-QD-PTX were higher than for unlabeled QD-PTX when tested on the human colon adenocarcinoma cell line HT-29. NT4-QD-PTX tumor-targeted nanoparticles can be considered promising for early tumor detection and for the development of effective treatments combining simultaneous therapy and diagnosis. |
format | Online Article Text |
id | pubmed-7179244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71792442020-04-28 A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment Brunetti, Jlenia Piantini, Sara Fragai, Marco Scali, Silvia Cipriani, Giulia Depau, Lorenzo Pini, Alessandro Falciani, Chiara Menichetti, Stefano Bracci, Luisa Molecules Article The development of selective tumor targeting agents to deliver multiple units of chemotherapy drugs to cancer tissue would improve treatment efficacy and greatly advance progress in cancer therapy. Here we report a new drug delivery system based on a tetrabranched peptide known as NT4, which is a promising cancer theranostic by virtue of its high cancer selectivity. We developed NT4 directly conjugated with one, two, or three units of paclitaxel and an NT4-based nanosystem, using NIR-emitting quantum dots, loaded with the NT4 tumor-targeting agent and conjugated with paclitaxel, to obtain a NT4-QD-PTX nanodevice designed to simultaneously detect and kill tumor cells. The selective binding and in vitro cytotoxicity of NT4-QD-PTX were higher than for unlabeled QD-PTX when tested on the human colon adenocarcinoma cell line HT-29. NT4-QD-PTX tumor-targeted nanoparticles can be considered promising for early tumor detection and for the development of effective treatments combining simultaneous therapy and diagnosis. MDPI 2020-02-28 /pmc/articles/PMC7179244/ /pubmed/32121130 http://dx.doi.org/10.3390/molecules25051088 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Brunetti, Jlenia Piantini, Sara Fragai, Marco Scali, Silvia Cipriani, Giulia Depau, Lorenzo Pini, Alessandro Falciani, Chiara Menichetti, Stefano Bracci, Luisa A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment |
title | A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment |
title_full | A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment |
title_fullStr | A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment |
title_full_unstemmed | A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment |
title_short | A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment |
title_sort | new nt4 peptide-based drug delivery system for cancer treatment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179244/ https://www.ncbi.nlm.nih.gov/pubmed/32121130 http://dx.doi.org/10.3390/molecules25051088 |
work_keys_str_mv | AT brunettijlenia anewnt4peptidebaseddrugdeliverysystemforcancertreatment AT piantinisara anewnt4peptidebaseddrugdeliverysystemforcancertreatment AT fragaimarco anewnt4peptidebaseddrugdeliverysystemforcancertreatment AT scalisilvia anewnt4peptidebaseddrugdeliverysystemforcancertreatment AT ciprianigiulia anewnt4peptidebaseddrugdeliverysystemforcancertreatment AT depaulorenzo anewnt4peptidebaseddrugdeliverysystemforcancertreatment AT pinialessandro anewnt4peptidebaseddrugdeliverysystemforcancertreatment AT falcianichiara anewnt4peptidebaseddrugdeliverysystemforcancertreatment AT menichettistefano anewnt4peptidebaseddrugdeliverysystemforcancertreatment AT bracciluisa anewnt4peptidebaseddrugdeliverysystemforcancertreatment AT brunettijlenia newnt4peptidebaseddrugdeliverysystemforcancertreatment AT piantinisara newnt4peptidebaseddrugdeliverysystemforcancertreatment AT fragaimarco newnt4peptidebaseddrugdeliverysystemforcancertreatment AT scalisilvia newnt4peptidebaseddrugdeliverysystemforcancertreatment AT ciprianigiulia newnt4peptidebaseddrugdeliverysystemforcancertreatment AT depaulorenzo newnt4peptidebaseddrugdeliverysystemforcancertreatment AT pinialessandro newnt4peptidebaseddrugdeliverysystemforcancertreatment AT falcianichiara newnt4peptidebaseddrugdeliverysystemforcancertreatment AT menichettistefano newnt4peptidebaseddrugdeliverysystemforcancertreatment AT bracciluisa newnt4peptidebaseddrugdeliverysystemforcancertreatment |